The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Roger Barker is the Professor of Clinical Neuroscience and an Honorary Consultant in Neurology at the University of Cambridge and at Addenbrooke's Hospital. Professor Barker combines basic research looking at novel therapies to treat chronic neurodegenerative disorders of the brain with clinically-based work aimed at better defining the heterogeneity and basis of such disorders. He is the co-ordinator of the TRANSEURO project looking at foetal cell grafting in patients with early Parkinson's disease and is part of the GFORCE PD initiative as well as Director of the ISSCR.